Can Plaque be Regressed?

Even a small reduction in plaque can lower cardiovascular risk. High-intensity interval training, medications, and lifestyle changes like a low-fat vegetarian diet and regular exercise are effective. Monitor your heart health for the best results!

The short answer: Yes—evidence shows it’s possible. Even a 1% reduction in plaque volume has been linked to a 20% lower risk of cardiovascular events.

What the research tells us: There’s more than one way to shrink plaque, as long as the root mechanisms (like LDL, inflammation, oxidative stress, etc.) are addressed.

 

  • Exercise – CENIT trial (2022)
    Supervised high-intensity interval training (HIIT) led to a −1.2% annual reduction in plaque volume (PAV). Control group? No change.

 

  • Ezetimibe – PRECISE-IVUS trial (2015)
    This non-statin LDL-lowering drug resulted in a −1.4% PAV reduction, with 78% of patients showing regression.

 

  • Combination therapy – ZEUS trial (2014)
    In diabetic ACS patients:

    • Statins alone: 5.1% plaque reduction

    • Statins + ezetimibe: 13.9% reduction
      Key takeaway: Lower LDL = more regression.

 

  • High-dose EPA – EVAPORATE trial (2020)
    EPA (icosapent ethyl, 4g/day) didn’t shrink plaque volume much, but changed its type—reducing vulnerable plaque by 17%. This highlights the power of reducing inflammation and oxidative stress, through supplements or even intensive dietary changes.

 

  • PCSK9 inhibitors – GLAGOV trial (2016)
    Evolocumab dropped PAV by −0.63% per year. Different drug, same outcome: lower LDL = less plaque.

 

  • Statins – SATURN trial (2011)
    Rosuvastatin reduced plaque by −0.42% to −0.50% per year. More statin = lower LDL = more regression.

 

  • Statins – ASTEROID trial (2006)
    High-dose rosuvastatin (40mg) showed a −0.49% per year reduction in plaque volume.

 

  • Nattokinase
    In a study of 1,062 participants, daily supplementation (10,800 FU/day for 12 months) significantly reduced carotid plaque size.
    Caution: No control group, so results are interesting but not conclusive. Still, nattokinase is considered safe when used properly.

 

  • Colchicine – EKSTROM trial
    An anti-inflammatory added to statin therapy, colchicine led to a −1.1% reduction in PAV in 1 year, even without lowering LDL. This highlights the role of inflammation in plaque buildup.

  • Lifestyle medicine – Ornish Lifestyle Heart trial
    A randomized controlled trial with major lifestyle changes:

    • Very low-fat, whole-food vegetarian diet

    • Aerobic exercise

    • Group support, stress management, and smoking cessation
      Results:

    • 1.75% reduction in blockage after 1 year

    • 3.1% after 5 years
      Meanwhile, the control group got worse.

 

Bottom line
Don’t assume. Test, don’t guess. Whether through exercise, medication, supplements, or lifestyle changes—plaque can shrink, but you need to monitor and adjust.

Here are some related heart highlights

Can Plaque be Regressed?

Even a small reduction in plaque can lower cardiovascular risk. High-intensity interval training, medications, and lifestyle changes like a low-fat vegetarian diet and regular...

What is Nattokinase

Discover the benefits of Nattokinase, a powerful enzyme from fermented soybeans known for supporting cardiovascular health. It promotes healthy blood flow, reduces blood clot...

Elevate your heart TODAY !

Elevate your heart health with our expert tips! Simple changes, like eating more fruits and exercising regularly, can enhance your wellness. Monitor your heart...

Cannabis use impairs vascular function

Research reveals that chronic cannabis use, whether through smoking or ingesting THC edibles, is associated with impaired vascular endothelial function, similar to what is...

Join our Facebook Community